Elsevier

The Journal of Pediatrics

Volume 123, Issue 5, November 1993, Pages 779-782
The Journal of Pediatrics

Congenital cytomegalovirus infection and neonatal auditory screening1

https://doi.org/10.1016/S0022-3476(05)80859-5Get rights and content

Auditory screening of newborn infants has been recommended on the basis of the presence of risk criteria, including congenital infection. We assessed the ability of risk criteria-based neonatal auditory brain stem response to identify infants with hearing loss resulting from congenital cytomegalovirus (CMV) infection. Data from 6 1/2 years of risk criteria-based neonatal auditory screening were compared with the results of screening of all newborn infants for congenital CMV infection. Infants with congenital CMV infection received follow-up hearing evaluations. Congenital CMV infection was found in 167 (1.3%) of 12,371 infants; 134 had follow-up hearing evaluations, and 14 (10.4%) had confirmed sensorineural hearing loss. The rate of sensorineural hearing loss resulting from congenital CMV infection was 14 per 12,371 infants, of 1.1 per 1000 live births; the rate of bilateral loss ≥50 dB was 0.6 per 1000. Although 2036 infants received auditory screening because of risk criteria, only 34 (20%) of 167 infants with congenital CMV infection were included. Only 2 (14%) of 14 children with sensorineural hearing loss caused by CMV were identified by risk criteria-based screening. We conclude that congenital CMV infection is an important cause of hearing impairment. Neonatal auditory screening based on the presence of risk criteria will fail to identify the majority of cases of sensorineural hearing loss caused by congenital CMV infection.

References (22)

  • DavidsonJ et al.

    Epidemiologic patterns in childhood hearing loss: a review

    Int J Pediatr Otorhinolaryngol

    (1989)
  • McFarlandWH et al.

    The importance of early intervention with severe childhood deafness

    Pediatr Ann

    (1980)
  • Yoshinaga-ItanoC

    Aural habilitation: a key to the acquisition of knowledge, language, and speech

  • Joint Committee on Infant Hearing

    Position statement 1982

    Pediatrics

    (1982)
  • Joint Committee on Infant Hearing

    1990 Position statement

    ASHA

    (1991)
  • DemmlerGJ

    Summary of a workshop on surveillance for congenital cytomegalovirus disease [Infectious Diseases Society of America and Centers for Disease Control]

    Reviews of Infectious Diseases

    (1991)
  • StagnoS

    Cytomegalovirus

  • FowlerKB et al.

    The outcome of congenital cytomegalovirus infection in relation to maternal antibody status

    N Engl J Med

    (1992)
  • HarrisS et al.

    Congenital cytomegalovirus infection and sensorineural hearing loss

    Ear Hear

    (1984)
  • BoppanaSB et al.

    Evaluation of a microtiter plate fluorescent antibody assay for rapid detection of human cytomegalovirus infections

    J Clin Microbiol

    (1992)
  • HallJW

    Handbook of auditory evoked responses

  • Cited by (118)

    • Hearing loss caused by CMV infection is correlated with reduced endocochlear potentials caused by strial damage in murine models

      2022, Hearing Research
      Citation Excerpt :

      Sensorineural hearing loss (SNHL) is the most common permanent disability resulting from congenital CMV infection (e.g. Demmler 1991; Foulon et al. 2012; Fowler et al. 1999; Hicks et al. 1993; Manicklal et al. 2013; Misono et al. 2011; Park et al. 2014; Pass et al. 2006; Royackers et al. 2011; Stagno et al. 1986).

    • Early Detection and Diagnosis of Infant Hearing Impairment

      2021, Cummings Pediatric Otolaryngology
    • Role of cochlear synaptopathy in cytomegalovirus infected mice and in children

      2020, International Journal of Pediatric Otorhinolaryngology
    • Cytomegalovirus infection during pregnancy: state of the science

      2020, American Journal of Obstetrics and Gynecology
    • Viral, Protozoan, and Related Intracranial Infections

      2018, Volpe's Neurology of the Newborn
    View all citing articles on Scopus
    1

    Supported by grants from the National Institutes of Health: theNational Institute of Child Health and Human Development (HD10699) and the General Clinical Research Center (RR0032).

    View full text